AU Patent

AU8374575A — Peptidecylopropylamides having lh-rh/fsh-activity

Assigned to Hoechst AG · Expires 1977-02-10 · 49y expired

What this patent protects

Patent listed against Bupivacaine Hydrochloride And Epinephrine.

Drugs covered by this patent

Bupivacaine Hydrochloride And Epinephrine (BUPIVACAINE) · Innocoll

Patent Metadata

Patent number: AU8374575A
Jurisdiction: AU
Classification: —
Expires: 1977-02-10
Drug substance claim: No
Drug product claim: No
Assignee: Hoechst AG
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.